VETOQUINOL Corporate brochure 2010 (year 2009)

AN INDEPENDENT BRAND 11 th LARGEST VETERINARY PHARMACEUTICAL COMPANY IN THE WORLD // 3 rd LARGEST ANIMAL HEALTH SPECIALIST // 1,550 EMPLOYEES // A PRESENCE IN 23 COUNTRIES // 5% EFFECTIVE MARKET SHARE // REVENUES OF € 252.2 MILLION, OF WHICH OVER 80% IS GENERATED ABROAD // No 2 IN POLAND // No 3 IN CANADA // No 5 IN FRANCE // No 6 IN IRELAND AND SWITZERLAND // No 7 IN GERMANY, ITALY AND AUSTRIA // No 1 IN EUROPE FOR FOOD SUPPLEMENTS AND METABOLIC MODIFIERS // No 3 N EUROPE FOR ANTIBIOTICS. The 11 th largest veterinary pharmaceutical company in the world and the 3 rd largest dedicated to animal health, Vétoquinol is first and foremost an independent, family-owned business. Deeply committed to its values, it has always enjoyed a close relationship with its vet clients. Vétoquinol’s growth and development strategy focuses on innovation and finding the right balance between two major markets: companion animals and livestock, bred for human food. Historically based in France, Vétoquinol currently develops, produces and distributes a wide range of more than 700 medical and non-medical products in Europe, North America and Asia-Pacific. With a presence in 23 countries through its subsidiaries, its strong network of 140 distributor partners provides visibility for its products in more than 100 countries. PROFILE ACTIVITY REPORT 2009 01